2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with Alloxan Diabetes in 1 studies
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robitaille, R | 1 |
| Dusseault, J | 1 |
| Henley, N | 1 |
| Rosenberg, L | 1 |
| Hallé, JP | 1 |
1 other study available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Alloxan Diabetes
| Article | Year |
|---|---|
Insulin-like growth factor II allows prolonged blood glucose normalization with a reduced islet cell mass transplantation.
Topics: Animals; Apoptosis; Blood Glucose; Cell Survival; Cells, Cultured; Diabetes Mellitus, Experimental; | 2003 |